SA19 Characterizing Exploratory Endpoints in Early Oncology Trials: Insights From Trial Registry Audit

Saba Bajwa(Fistulacure), Kapil Khambholja(Maharaja Sayajirao University of Baroda), V Chhaya

Value in Health

December 1, 2025

10.1016/j.jval.2025.09.2961

Cited by 0

Related Papers

Potential of herbs in skin protection from ultraviolet radiation

|Pharmacognosy Reviews/Bioinformatics Trends/Pharmacognosy review|2011|355

Potential repurposing of Favipiravir in COVID-19 outbreak based on current evidence

|Travel Medicine and Infectious Disease|2020|40

Use of Structured Template and Reporting Tool for Real-World Evidence for Critical Appraisal of the Quality of Reporting of Real-World Evidence Studies: A Systematic Review

|Value in Health|2022|9

Comparison of anti microbial activity of Bhallataka Rasayana and its ingredient.

|Unknown|2009|5

Prognostic value of tumour-associated regulatory T-cells as a biomarker in non-small cell lung cancer: a systematic review and meta-analysis

|Systematic Reviews|2024|5